Quick Answer
AtriCure, Inc. reported Net Income Loss of -$11.45 million for the year ending 2025.
- AtriCure, Inc. showed an increase of +74.4% in Net Income Loss from 2024 to 2025.
- This data is from AtriCure, Inc.'s annual report (Form 10-K), filed with the SEC on February 19, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2014: -$7.71 million | Q2 2014: -$2.69 million | Q3 2014: -$466.0 thousand | Q4 2014: -$5.34 million | Q1 2015: -$5.27 million | Q2 2015: -$4.89 million | Q3 2015: -$6.14 million | Q4 2015: -$10.91 million | Q1 2016: -$9.72 million | Q2 2016: -$8.21 million | Q3 2016: -$6.78 million | Q4 2016: -$8.63 million | Q1 2017: -$10.18 million | Q2 2017: -$6.88 million | Q3 2017: -$7.25 million | Q4 2017: -$2.58 million | Q1 2018: -$10.13 million | Q2 2018: -$338.0 thousand | Q3 2018: -$7.24 million | Q4 2018: -$3.43 million | Q1 2019: -$5.64 million | Q2 2019: -$4.10 million | Q3 2019: -$9.36 million | Q4 2019: -$16.10 million | Q1 2020: -$16.41 million | Q2 2020: -$8.24 million | Q3 2020: -$4.95 million | Q4 2020: -$18.56 million | Q1 2021: -$16.92 million | Q2 2021: -$16.25 million | Q3 2021: $97.11 million | Q1 2022: -$15.18 million | Q2 2022: -$14.84 million | Q3 2022: -$12.27 million | Q1 2023: -$6.48 million | Q2 2023: -$5.12 million | Q3 2023: -$9.06 million | Q1 2024: -$13.27 million | Q2 2024: -$8.01 million | Q3 2024: -$7.85 million | Q1 2025: -$6.75 million | Q2 2025: -$6.19 million | Q3 2025: -$267.0 thousand.
- Over the full 17 years of available data (2009 to 2025), AtriCure, Inc.'s Net Income Loss has grown by 30.6%.
- Historical annual values: Fiscal year 2025: -$11.45 million | Fiscal year 2024: -$44.70 million | Fiscal year 2023: -$30.44 million | Fiscal year 2022: -$46.47 million | Fiscal year 2021: $50.20 million | Fiscal year 2020: -$48.16 million | Fiscal year 2019: -$35.19 million | Fiscal year 2018: -$21.14 million | Fiscal year 2017: -$26.89 million | Fiscal year 2016: -$33.34 million | Fiscal year 2015: -$27.21 million | Fiscal year 2014: -$16.21 million | Fiscal year 2013: -$11.46 million | Fiscal year 2012: -$7.53 million | Fiscal year 2011: -$5.46 million | Fiscal year 2010: -$3.79 million | Fiscal year 2009: -$16.49 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: